Robbinsville, NJ, United States of America

Richard Michael Corbett


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Richard Michael Corbett

Introduction

Richard Michael Corbett is a notable inventor based in Robbinsville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. His work exemplifies the intersection of innovation and healthcare.

Latest Patents

Richard Michael Corbett holds a patent for a process for preparing pyrrolotriazine. This invention provides a method for preparing compounds that inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2, and HER4. These compounds are valuable as antiproliferative agents for the treatment of cancer and other diseases. He has 1 patent to his name, showcasing his innovative approach to addressing critical health challenges.

Career Highlights

Corbett is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at the company allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise and dedication have positioned him as a key player in the field.

Collaborations

Throughout his career, Richard has collaborated with talented individuals such as Shankar Swaminathan and Ashvinikumar V Gavai. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Richard Michael Corbett's contributions to the pharmaceutical industry through his innovative patent and collaborations highlight the importance of research and development in combating diseases. His work continues to inspire future innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…